[
  {
    "publication_date": "2025-09-25",
    "issuer": "INFANT BACTERIAL THERAPEUTICS AB",
    "lei": "2138008KVBXCRJGP6Z26",
    "reporting_person": "Anders Kronström",
    "person_in_leading_position": "Anders Kronström",
    "position": "Annan ledande befattningshavare",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "Ja",
    "character": "Tilldelning",
    "category": "other",
    "instrument_type": "Option",
    "instrument_name": "Personaloptionsprogram 2025/2028",
    "isin": "",
    "transaction_date": "2025-09-25",
    "volume": 32500.0,
    "volume_raw": "32500,0",
    "volume_unit": "Antal",
    "price": 0.0,
    "price_raw": "0,0",
    "currency": "SEK",
    "trading_venue": "Utanför handelsplats",
    "transaction_value": 0.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-09-25",
    "issuer": "INFANT BACTERIAL THERAPEUTICS AB",
    "lei": "2138008KVBXCRJGP6Z26",
    "reporting_person": "Maria Ekdahl",
    "person_in_leading_position": "Maria Ekdahl",
    "position": "Ekonomichef/finanschef/finansdirektör",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "Ja",
    "character": "Tilldelning",
    "category": "other",
    "instrument_type": "Option",
    "instrument_name": "Personaloptionsprogram 2025/2028",
    "isin": "",
    "transaction_date": "2025-09-25",
    "volume": 32500.0,
    "volume_raw": "32500,0",
    "volume_unit": "Antal",
    "price": 0.0,
    "price_raw": "0,0",
    "currency": "SEK",
    "trading_venue": "Utanför handelsplats",
    "transaction_value": 0.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-09-25",
    "issuer": "INFANT BACTERIAL THERAPEUTICS AB",
    "lei": "2138008KVBXCRJGP6Z26",
    "reporting_person": "Staffan Strömberg",
    "person_in_leading_position": "Staffan Strömberg",
    "position": "Verkställande direktör (VD)",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "Ja",
    "character": "Tilldelning",
    "category": "other",
    "instrument_type": "Option",
    "instrument_name": "Personal optionsprogram 25/28",
    "isin": "",
    "transaction_date": "2025-09-25",
    "volume": 65000.0,
    "volume_raw": "65000,0",
    "volume_unit": "Antal",
    "price": 0.0,
    "price_raw": "0,0",
    "currency": "SEK",
    "trading_venue": "Utanför handelsplats",
    "transaction_value": 0.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-05-08",
    "issuer": "INFANT BACTERIAL THERAPEUTICS AB",
    "lei": "2138008KVBXCRJGP6Z26",
    "reporting_person": "Anthon Jahreskog",
    "person_in_leading_position": "Anthon Jahreskog",
    "position": "Styrelseledamot",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Aktie",
    "instrument_name": "Infant Bacterial Therapeutics AB ser. B",
    "isin": "SE0008015259",
    "transaction_date": "2025-05-08",
    "volume": 76.0,
    "volume_raw": "76,0",
    "volume_unit": "Antal",
    "price": 60.6,
    "price_raw": "60,6",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 4605.6,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-05-08",
    "issuer": "INFANT BACTERIAL THERAPEUTICS AB",
    "lei": "2138008KVBXCRJGP6Z26",
    "reporting_person": "Anthon Jahreskog",
    "person_in_leading_position": "Anthon Jahreskog",
    "position": "Styrelseledamot",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Aktie",
    "instrument_name": "Infant Bacterial Therapeutics AB ser. B",
    "isin": "SE0008015259",
    "transaction_date": "2025-05-08",
    "volume": 82.0,
    "volume_raw": "82,0",
    "volume_unit": "Antal",
    "price": 60.8,
    "price_raw": "60,8",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 4985.599999999999,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-05-08",
    "issuer": "INFANT BACTERIAL THERAPEUTICS AB",
    "lei": "2138008KVBXCRJGP6Z26",
    "reporting_person": "Anthon Jahreskog",
    "person_in_leading_position": "Anthon Jahreskog",
    "position": "Styrelseledamot",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Aktie",
    "instrument_name": "Infant Bacterial Therapeutics AB ser. B",
    "isin": "SE0008015259",
    "transaction_date": "2025-05-08",
    "volume": 81.0,
    "volume_raw": "81,0",
    "volume_unit": "Antal",
    "price": 61.0,
    "price_raw": "61,0",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 4941.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-05-08",
    "issuer": "INFANT BACTERIAL THERAPEUTICS AB",
    "lei": "2138008KVBXCRJGP6Z26",
    "reporting_person": "Anthon Jahreskog",
    "person_in_leading_position": "Anthon Jahreskog",
    "position": "Styrelseledamot",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Aktie",
    "instrument_name": "Infant Bacterial Therapeutics AB ser. B",
    "isin": "SE0008015259",
    "transaction_date": "2025-05-08",
    "volume": 81.0,
    "volume_raw": "81,0",
    "volume_unit": "Antal",
    "price": 61.2,
    "price_raw": "61,2",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 4957.2,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-05-08",
    "issuer": "INFANT BACTERIAL THERAPEUTICS AB",
    "lei": "2138008KVBXCRJGP6Z26",
    "reporting_person": "Anthon Jahreskog",
    "person_in_leading_position": "Anthon Jahreskog",
    "position": "Styrelseledamot",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Aktie",
    "instrument_name": "Infant Bacterial Therapeutics AB ser. B",
    "isin": "SE0008015259",
    "transaction_date": "2025-05-08",
    "volume": 524.0,
    "volume_raw": "524,0",
    "volume_unit": "Antal",
    "price": 61.2,
    "price_raw": "61,2",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 32068.800000000003,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-05-08",
    "issuer": "INFANT BACTERIAL THERAPEUTICS AB",
    "lei": "2138008KVBXCRJGP6Z26",
    "reporting_person": "Anthon Jahreskog",
    "person_in_leading_position": "Anthon Jahreskog",
    "position": "Styrelseledamot",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Aktie",
    "instrument_name": "Infant Bacterial Therapeutics AB ser. B",
    "isin": "SE0008015259",
    "transaction_date": "2025-05-08",
    "volume": 511.0,
    "volume_raw": "511,0",
    "volume_unit": "Antal",
    "price": 61.4,
    "price_raw": "61,4",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 31375.399999999998,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2024-11-16",
    "issuer": "INFANT BACTERIAL THERAPEUTICS AB",
    "lei": "2138008KVBXCRJGP6Z26",
    "reporting_person": "Mattias Nilsson",
    "person_in_leading_position": "Maria Ekdahl",
    "position": "Ekonomichef/finanschef/finansdirektör",
    "closely_associated": "Ja",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Aktie",
    "instrument_name": "Infant Bacterial Therapeutics AB ser. B",
    "isin": "SE0008015259",
    "transaction_date": "2024-11-14",
    "volume": 500.0,
    "volume_raw": "500,0",
    "volume_unit": "Antal",
    "price": 34.0,
    "price_raw": "34,0",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 17000.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2024-09-03",
    "issuer": "INFANT BACTERIAL THERAPEUTICS AB",
    "lei": "2138008KVBXCRJGP6Z26",
    "reporting_person": "Mattias Nilsson",
    "person_in_leading_position": "Maria Ekdahl",
    "position": "Ekonomichef/finanschef/finansdirektör",
    "closely_associated": "Ja",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Aktie",
    "instrument_name": "Infant Bacterial Therapeutics AB ser. B",
    "isin": "SE0008015259",
    "transaction_date": "2024-09-02",
    "volume": 1000.0,
    "volume_raw": "1000,0",
    "volume_unit": "Antal",
    "price": 25.5,
    "price_raw": "25,5",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 25500.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2024-09-03",
    "issuer": "INFANT BACTERIAL THERAPEUTICS AB",
    "lei": "2138008KVBXCRJGP6Z26",
    "reporting_person": "Anthon Jahreskog",
    "person_in_leading_position": "Anthon Jahreskog",
    "position": "Styrelseledamot",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Aktie",
    "instrument_name": "Infant Bacterial Therapeutics AB ser. B",
    "isin": "SE0008015259",
    "transaction_date": "2024-09-02",
    "volume": 11000.0,
    "volume_raw": "11000,0",
    "volume_unit": "Antal",
    "price": 25.0,
    "price_raw": "25,0",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 275000.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2024-09-03",
    "issuer": "INFANT BACTERIAL THERAPEUTICS AB",
    "lei": "2138008KVBXCRJGP6Z26",
    "reporting_person": "Anthon Jahreskog",
    "person_in_leading_position": "Anthon Jahreskog",
    "position": "Styrelseledamot",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Aktie",
    "instrument_name": "Infant Bacterial Therapeutics AB ser. B",
    "isin": "SE0008015259",
    "transaction_date": "2024-09-02",
    "volume": 3000.0,
    "volume_raw": "3000,0",
    "volume_unit": "Antal",
    "price": 25.0,
    "price_raw": "25,0",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 75000.0,
    "status": "Aktuell",
    "is_current_report": true
  }
]